Cognitive Decline/Dementia

A clinical biopharmaceutical company has announced completion of the clinical portion of its phase 2a multiple ascending dose study examining safety and tolerability of AL001 for dementia related to Alzheimer’s disease.

Linus Health announced a collaboration with Goizueta Institute @Emory Brain Health and The Seavey Clinic at Emory Healthcare to implement digital cognitive assessments in primary care for early detection of Alzheimer’s disease.

The Alzheimer’s Association is among a group of professional societies and research institutions that have launched the Alzheimer’s Network for Treatment and Diagnostics to collect data on patients treated with novel FDA-approved therapies.

The National Center of Excellence in Research on Parkinson’s Disease in Luxembourg has launched an online survey in collaboration with regional research centers to improve risk prediction for neurodegenerative diseases.

Long-term supplementation with spermidine improved neither memory function nor biomarkers compared with placebo in older adults with subjective cognitive decline, according to results of a clinical trial published in JAMA Network Open.

Increases in generalized and visceral adipose tissue were linked to reduction of cognitive function in adults, when adjusted for other health factors, per a Canadian cross-sectional cohort study published in JAMA Network Open.

Intensive blood pressure reduction did not appear to prevent cognitive decline and dementia, according to results of a systematic review and meta-analysis published in JAMA Network Open.

National Minority Health Month originated in 1915 with the establishment of National Negro Health Week by educator Booker T. Washington.

Healio Psychiatry has compiled a list of its five most-viewed stories in March.